Epidemiological, Clinical and Histopathological Profile of Squamous Cell Carcinoma of the Bladder in Guinea
- 1 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 2 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 3 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 4 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 5 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 6 Urology Department, AK Eramishantsev Municipal Clinical Hospital, Peoples’ Friendship University of Moscow, Moscow, Russia
- 7 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 8 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
- 9 Urology Department, Ignace Deen University Hospital, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
Abstract
Introduction: Bladder squamous cell carcinoma, closely associated with endemic urinary schistosomiasis in sub-Saharan Africa, presents distinctive characteristics. This study aimed to describe the sociodemographic, clinical, and histopathological profile of this disease in Guinea. Methodology: A retrospective descriptive study was conducted at Conakry University Hospital between January 2015 and December 2024, including 35 patients with histologically confirmed bladder squamous cell carcinoma. Sociodemographic, clinical, cystoscopic, and histopathological data were analyzed. Results: The mean age was 57.4 years with predominance in the 60 - 69 age group (42.86%). Female predominance was observed (male-to-female ratio 0.59:1). Freshwater bathing was the main risk factor (80%). Hematuria was the primary presenting symptom (88.57%). Diagnosis was late, with 57.14% of patients having ECOG ≥ 3 and 54.29% presenting with renal failure. Tumors were predominantly solid (85.71%), sessile (91.43%), and multifocal (88.57%), with large size (median 7.8 cm) and ureteral orifice involvement (71.43%). Histological analysis revealed 91.43% muscle-invasive tumors and 97.14% high-grade tumors. Schistosoma haematobium eggs were identified in 34.29% of specimens. Conclusion: Bladder squamous cell carcinoma is associated with vesical schistosomiasis in Guinea and characterized by late diagnosis at the muscle-invasive stage. Strengthening schistosomiasis prevention and improving early detection are essential to enhance prognosis.
- Filho, A.M., Briganti, A., Jemal, A. and Bray, F. (2025) Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. European Urology . https://doi.org/10.1016/j.eururo.2025.12.011
- Jalloh, M., Cassell, A., Diallo, T., Gaye, O., Ndoye, M., Mbodji, M.M., et al. (2020) Is Schistosomiasis a Risk Factor for Bladder Cancer? Evidence-Based Facts. Journal of Tropical Medicine , 2020, Article ID: 8270810. https://doi.org/10.1155/2020/8270810
- Rambau, P.F., Chalya, P.L. and Jackson, K. (2013) Schistosomiasis and Urinary Bladder Cancer in North Western Tanzania: A Retrospective Review of 185 Patients. Infectious Agents and Cancer , 8, Article No. 19. https://doi.org/10.1186/1750-9378-8-19
- Yohana, C., Bakuza, J.S., Kinung’hi, S.M., Nyundo, B.A. and Rambau, P.F. (2023) The Trend of Schistosomiasis Related Bladder Cancer in the Lake Zone, Tanzania: A Retrospective Review over 10 Years Period. Infectious Agents and Cancer , 18, Article No. 10. https://doi.org/10.1186/s13027-023-00491-1
- Bowa, K., Mulele, C., Kachimba, J., Manda, E., Mapulanga, V. and Mukosai, S. (2018) A Review of Bladder Cancer in Sub-Saharan Africa: A Different Disease, with a Distinct Presentation, Assessment, and Treatment. Annals of African Medicine , 17, 99-105. https://doi.org/10.4103/aam.aam_48_17
- Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A. (2023) Cancer Statistics, 2023. CA : A Cancer Journal for Clinicians , 73, 17-48. https://doi.org/10.3322/caac.21763
- Felix, A.S., Soliman, A.S., Khaled, H., Zaghloul, M.S., Banerjee, M., El-Baradie, M., et al. (2008) The Changing Patterns of Bladder Cancer in Egypt over the Past 26 Years. Cancer Causes & Control , 19, 421-429. https://doi.org/10.1007/s10552-007-9104-7
- Mostafa, M.H., Sheweita, S.A. and O’Connor, P.J. (1999) Relationship between Schistosomiasis and Bladder Cancer. Clinical Microbiology Reviews , 12, 97-111. https://doi.org/10.1128/CMR.12.1.97
- Honeycutt, J., Hammam, O., Fu, C.L. and Hsieh, M.H. (2014) Controversies and Challenges in Research on Urogenital Schistosomiasis-Associated Bladder Cancer. Trends in Parasitology , 30, 324-332. https://doi.org/10.1016/j.pt.2014.05.004
- Gouda, I., Mokhtar, N., Bilal, D., El-Bolkainy, T. and El-Bolkainy, N.M. (2007) Bilharziasis and Bladder Cancer: A Time Trend Analysis of 9843 Patients. Journal of the Egyptian National Cancer Institute , 19, 158-162.
- International Agency for Research on Cancer (2012) Biological Agents. Volume 100 B. A Review of Human Carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 100, 1-441.